ValuEngine lowered shares of Tenet Healthcare (NYSE:THC) from a hold rating to a sell rating in a report published on Friday.

THC has been the subject of a number of other research reports. Zacks Investment Research downgraded shares of Tenet Healthcare from a buy rating to a hold rating in a research report on Monday, August 13th. JPMorgan Chase & Co. upped their price objective on shares of Tenet Healthcare from $22.00 to $28.00 and gave the stock an underweight rating in a research report on Friday, August 10th. SunTrust Banks restated a hold rating and set a $35.00 price objective on shares of Tenet Healthcare in a research report on Wednesday, August 8th. Jefferies Financial Group downgraded shares of Tenet Healthcare from a buy rating to a hold rating and upped their price objective for the stock from $28.00 to $38.00 in a research report on Friday, June 29th. Finally, Citigroup upped their price objective on shares of Tenet Healthcare from $37.00 to $44.00 and gave the stock a buy rating in a research report on Monday, July 23rd. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of $30.80.

THC stock traded down $0.04 on Friday, hitting $25.39. The company’s stock had a trading volume of 1,156,329 shares, compared to its average volume of 1,912,491. Tenet Healthcare has a 1 year low of $12.25 and a 1 year high of $39.74. The company has a market cap of $2.91 billion, a price-to-earnings ratio of 31.35, a price-to-earnings-growth ratio of 1.27 and a beta of 0.92. The company has a debt-to-equity ratio of 24.66, a current ratio of 1.08 and a quick ratio of 1.01.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Monday, August 6th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.25 by $0.24. Tenet Healthcare had a negative net margin of 2.51% and a positive return on equity of 38.91%. The firm had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.57 billion. During the same quarter in the prior year, the firm earned ($0.17) EPS. Tenet Healthcare’s revenue for the quarter was down 6.2% on a year-over-year basis. As a group, analysts anticipate that Tenet Healthcare will post 1.73 earnings per share for the current year.

Several large investors have recently bought and sold shares of the company. Assetmark Inc. grew its stake in Tenet Healthcare by 45.8% in the 2nd quarter. Assetmark Inc. now owns 5,093 shares of the company’s stock valued at $171,000 after acquiring an additional 1,601 shares during the last quarter. Arizona State Retirement System grew its stake in Tenet Healthcare by 3.6% in the 2nd quarter. Arizona State Retirement System now owns 56,681 shares of the company’s stock valued at $1,903,000 after acquiring an additional 1,959 shares during the last quarter. Amalgamated Bank grew its stake in Tenet Healthcare by 16.9% in the 2nd quarter. Amalgamated Bank now owns 13,634 shares of the company’s stock valued at $458,000 after acquiring an additional 1,970 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its stake in Tenet Healthcare by 5.4% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 48,312 shares of the company’s stock valued at $1,622,000 after acquiring an additional 2,470 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Tenet Healthcare by 48.5% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,267 shares of the company’s stock valued at $278,000 after acquiring an additional 2,700 shares during the last quarter.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also: How to calculate the intrinsic value of a stock

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.